Related Experiment Video
Updated: Jan 13, 2026

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
The Rasch-transformed gastrointestinal symptoms rating scale in myotonic dystrophy type 1 (RT-GSRS-DM1)
Leandre A la Fontaine1,2, Basil Pap van Veen1,2, Tatiana Hamadeh1,2
1Department of Neurology, Maastricht University Medical Center, Maastricht, The Netherlands.
Developing a disease-specific gastrointestinal (GI) symptom measure for Myotonic Dystrophy type 1 (DM1) is challenging. The widely used GSRS questionnaire requires further refinement for accurate patient assessment in DM1.
Area of Science:
- Neurology
- Gastroenterology
- Medical Informatics
Background:
- Myotonic Dystrophy type 1 (DM1) is a multisystemic neuromuscular disorder with significant, yet under-assessed, gastrointestinal (GI) symptoms impacting patient quality of life.
- Currently, no disease-specific GI symptom questionnaire exists for DM1 patients.
- The established Gastrointestinal Symptoms Rating Scale (GSRS) lacks validation using modern clinimetric standards for DM1.
Purpose of the Study:
- To evaluate the suitability of the GSRS for DM1 patients using Rasch analysis.
- To develop a disease-specific, interval-level GI symptom measure for DM1.
Main Methods:
- Rasch analysis was employed to assess item fit, threshold ordering, differential item functioning (DIF), local dependency, and unidimensionality.
- Model fit was determined using chi-square statistics, item and person fit residuals, and the Person Separation Index (PSI).
Main Results:
- The initial GSRS data from 403 DM1 patients did not meet Rasch model expectations.
- Three items (hard stools, heartburn, diarrhea) were removed; nausea was split by age; constipation was retained despite misfit due to clinical relevance.
- The final model did not fully meet Rasch requirements, though an acceptable Person Separation Index (0.76) was achieved.
Conclusions:
- Measuring GI symptoms in DM1 presents significant challenges.
- This study represents a crucial initial step toward developing a more accurate and patient-centered GI symptom measure for DM1.
- Further research is necessary to create a validated questionnaire that accurately reflects the patient experience in DM1.
More Related Videos
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
14:55Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI
Published on: April 18, 2011
Related Concept Videos
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Gastrointestinal Motility Disorders
Assessment of the Gastrointestinal System II: Health Perception Pattern
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...